Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
This list of potential positions covers Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty
Mettler Toledo International (MTD)
The company has Return on Asset of 0.1985 % which means that on every $100 spent on assets, it made $0.1985 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2951 %, implying that it generated $0.2951 on every 100 dollars invested. Mettler Toledo's management efficiency ratios could be used to measure how well Mettler Toledo manages its routine affairs as well as how well it operates its assets and liabilities. At present, Mettler Toledo's Return On Capital Employed is projected to increase slightly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.25, whereas Return On Equity is projected to grow to (5.00). At present, Mettler Toledo's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 37.2 M, whereas Non Current Assets Total are forecasted to decline to about 1.3 B. The entity currently falls under 'Large-Cap' category with a total capitalization of 26.23 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mettler Toledo's market, we take the total number of its shares issued and multiply it by Mettler Toledo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be overvalued. Mettler Toledo Inter secures a last-minute Real Value of $1097.61 per share. The latest price of the firm is $1253.78. Our model forecasts the value of Mettler Toledo Inter from analyzing the firm fundamentals such as Profit Margin of 0.21 %, current valuation of 28.54 B, and Return On Equity of 0.3 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend purchasing undervalued stocks and exiting overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Cardinal Health (CAH)
The company has Return on Asset of 0.0279 % which means that on every $100 spent on assets, it made $0.0279 of profit. This is way below average. Cardinal Health's management efficiency ratios could be used to measure how well Cardinal Health manages its routine affairs as well as how well it operates its assets and liabilities. The Cardinal Health's current Return On Capital Employed is estimated to increase to 0.17, while Return On Tangible Assets are projected to decrease to 0.05. As of now, Cardinal Health's Total Current Assets are increasing as compared to previous years. The Cardinal Health's current Intangible Assets is estimated to increase to about 2.2 B, while Non Current Assets Total are projected to decrease to under 6.4 B. The entity currently falls under 'Large-Cap' category with a total capitalization of 25.06 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cardinal Health's market, we take the total number of its shares issued and multiply it by Cardinal Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
The company has Return on Asset of 0.1191 % which means that on every $100 spent on assets, it made $0.1191 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2239 %, implying that it generated $0.2239 on every 100 dollars invested. ResMed's management efficiency ratios could be used to measure how well ResMed manages its routine affairs as well as how well it operates its assets and liabilities. As of May 2, 2024, Return On Tangible Assets is expected to decline to 0.13. In addition to that, Return On Capital Employed is expected to decline to 0.14. At present, ResMed's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 477.5 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 42.6 M. This firm currently falls under 'Large-Cap' category with a total capitalization of 31.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ResMed's market, we take the total number of its shares issued and multiply it by ResMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be overvalued. ResMed Inc holds a recent Real Value of $168.33 per share. The prevailing price of the company is $216.3. Our model determines the value of ResMed Inc from analyzing the company fundamentals such as Return On Equity of 0.22, shares outstanding of 146.91 M, and Operating Margin of 0.31 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support purchasing undervalued entities and exiting overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Masimo (MASI)
The company has return on total asset (ROA) of 0.0293 % which means that it generated a profit of $0.0293 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0603 %, meaning that it created $0.0603 on every $100 dollars invested by stockholders. Masimo's management efficiency ratios could be used to measure how well Masimo manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Masimo's Return On Tangible Assets are decreasing as compared to previous years. The Masimo's current Return On Capital Employed is estimated to increase to 0.14, while Return On Assets are projected to decrease to 0.04. As of now, Masimo's Total Current Assets are increasing as compared to previous years. The Masimo's current Intangible Assets is estimated to increase to about 1.3 B, while Non Currrent Assets Other are forecasted to increase to (481.5 M). The entity currently falls under 'Mid-Cap' category with a current market capitalization of 7.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Masimo's market, we take the total number of its shares issued and multiply it by Masimo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.
Macroaxis Gross Profit
Macroaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Macroaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Macroaxis Gross Profit growth over the last 10 years. Please check Macroaxis' gross profit and other fundamental indicators for more details.
Story appears to be empty
Mettler Toledo International (MTD)
The company has Return on Asset of 0.1985 % which means that on every $100 spent on assets, it made $0.1985 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2951 %, implying that it generated $0.2951 on every 100 dollars invested. Mettler Toledo's management efficiency ratios could be used to measure how well Mettler Toledo manages its routine affairs as well as how well it operates its assets and liabilities. At present, Mettler Toledo's Return On Capital Employed is projected to increase slightly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.25, whereas Return On Equity is projected to grow to (5.00). At present, Mettler Toledo's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 37.2 M, whereas Non Current Assets Total are forecasted to decline to about 1.3 B. The entity currently falls under 'Large-Cap' category with a total capitalization of 26.23 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mettler Toledo's market, we take the total number of its shares issued and multiply it by Mettler Toledo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be overvalued. Mettler Toledo Inter secures a last-minute Real Value of $1097.61 per share. The latest price of the firm is $1253.78. Our model forecasts the value of Mettler Toledo Inter from analyzing the firm fundamentals such as Profit Margin of 0.21 %, current valuation of 28.54 B, and Return On Equity of 0.3 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend purchasing undervalued stocks and exiting overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Cardinal Health (CAH)
The company has Return on Asset of 0.0279 % which means that on every $100 spent on assets, it made $0.0279 of profit. This is way below average. Cardinal Health's management efficiency ratios could be used to measure how well Cardinal Health manages its routine affairs as well as how well it operates its assets and liabilities. The Cardinal Health's current Return On Capital Employed is estimated to increase to 0.17, while Return On Tangible Assets are projected to decrease to 0.05. As of now, Cardinal Health's Total Current Assets are increasing as compared to previous years. The Cardinal Health's current Intangible Assets is estimated to increase to about 2.2 B, while Non Current Assets Total are projected to decrease to under 6.4 B. The entity currently falls under 'Large-Cap' category with a total capitalization of 25.06 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cardinal Health's market, we take the total number of its shares issued and multiply it by Cardinal Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
The company has Return on Asset of 0.1191 % which means that on every $100 spent on assets, it made $0.1191 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2239 %, implying that it generated $0.2239 on every 100 dollars invested. ResMed's management efficiency ratios could be used to measure how well ResMed manages its routine affairs as well as how well it operates its assets and liabilities. As of May 2, 2024, Return On Tangible Assets is expected to decline to 0.13. In addition to that, Return On Capital Employed is expected to decline to 0.14. At present, ResMed's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 477.5 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 42.6 M. This firm currently falls under 'Large-Cap' category with a total capitalization of 31.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ResMed's market, we take the total number of its shares issued and multiply it by ResMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be overvalued. ResMed Inc holds a recent Real Value of $168.33 per share. The prevailing price of the company is $216.3. Our model determines the value of ResMed Inc from analyzing the company fundamentals such as Return On Equity of 0.22, shares outstanding of 146.91 M, and Operating Margin of 0.31 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support purchasing undervalued entities and exiting overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Masimo (MASI)
The company has return on total asset (ROA) of 0.0293 % which means that it generated a profit of $0.0293 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0603 %, meaning that it created $0.0603 on every $100 dollars invested by stockholders. Masimo's management efficiency ratios could be used to measure how well Masimo manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Masimo's Return On Tangible Assets are decreasing as compared to previous years. The Masimo's current Return On Capital Employed is estimated to increase to 0.14, while Return On Assets are projected to decrease to 0.04. As of now, Masimo's Total Current Assets are increasing as compared to previous years. The Masimo's current Intangible Assets is estimated to increase to about 1.3 B, while Non Currrent Assets Other are forecasted to increase to (481.5 M). The entity currently falls under 'Mid-Cap' category with a current market capitalization of 7.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Masimo's market, we take the total number of its shares issued and multiply it by Masimo's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Did you try this?
Run Pair Correlation Now
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
